Latest Share Issuance News

Aldoro Resources has defined high-priority gold targets at its Damara Gold Project and confirmed significant rare earth and associated mineralisation at Kameelburg, with drilling and metallurgical progress underpinning its dual-commodity strategy.

Chariot Resources advances its Nigerian lithium acquisition with six licences transferred and spodumene confirmed in samples, while raising A$2.15 million and securing a A$3.5 million loan refinancing.

Brazilian Rare Earths (ASX: BRE) has reported substantial expansion of its Monte Alto rare earth project with ultra high-grade drilling results and validated low-temperature processing delivering 97% recovery. The company also secured a Trial Mining Licence enabling early production and bulk shipments.

Rokeby Resources (ASX:RKB) has secured the Omeo Gold Project in Victoria, adding a historical resource of 320,000 ounces at 4.0 g/t Au and launching a $4 million capital raise. The acquisition ushers in leadership changes and sets a clear path for resource expansion.

Brazilian Critical Minerals (ASX: BCM) has reinforced the scale and quality of its Ema rare earth project with strong drilling results and steady progress on permitting and feasibility studies, positioning it well amid tightening global supply.

Peninsula Energy has won a Supreme Court ruling validating a contentious nearly 20 million share issuance from February despite prospectus lapses, prompting a request to lift its trading suspension.

Taiton Resources has completed a partial placement of 9.55 million shares to sophisticated investors, extending related option expiry dates to June 2029. A further tranche awaits due to delayed funds, while the company continues to advance exploration projects across South Australia and New South Wales.

Peninsula Energy (ASX: PEN) has voluntarily suspended trading of its shares pending a Supreme Court decision on the validity of share sales made earlier this year. The court hearing, set for 22 April, will determine if required disclosures were properly made for sales between February and April 2026.

Accordant Group Limited’s shareholders have approved a significant share issuance under a Rights Offer, allowing the Hull Family Trust to increase its voting control beyond 20%. The move also greenlights additional share allocations to related parties to cover subscription shortfalls.

Henderson Far East Income Limited posted a robust 23.3% net asset value total return for the half-year ending February 2026, supported by strong Asian tech and financial sector gains. The trust declared a 6.25p interim dividend and raised £39.1 million through new share issuance, securing a spot in the FTSE 250.

Mesoblast has acquired exclusive rights to a patented chimeric antigen receptor platform designed to enhance the targeting and potency of its mesenchymal stromal cell therapies, aiming to expand treatment options for inflammatory and autoimmune diseases.

Vectus Biosystems has completed the sale of its VB4-P5 renal fibrosis compound to Canadian biotech XORTX, receiving a near 10% equity stake and warrants. This move aligns with Vectus’ strategy to develop drug candidates to a stage attractive to partners while focusing on its lead compound VB0004.